{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T22:05:45Z","timestamp":1775167545959,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T00:00:00Z","timestamp":1752192000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T00:00:00Z","timestamp":1752192000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-08752-2","type":"journal-article","created":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T06:10:27Z","timestamp":1752214227000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["TMEM150A overexpression was associated with poor prognosis and cancer progression in glioma verified by comprehensive analysis and cell experiments"],"prefix":"10.1038","volume":"15","author":[{"given":"Hao-Qiang","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi-Hao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Qiong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,11]]},"reference":[{"issue":"9","key":"8752_CR1","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1097\/CAD.0000000000000890","volume":"31","author":"L Zhang","year":"2020","unstructured":"Zhang, L., Wu, F. & Zhao, J. Transmembrane protein 45A regulates the proliferation, migration, and invasion of glioma cells through nuclear factor kappa-B. Anticancer Drugs. 31(9), 900\u2013907. https:\/\/doi.org\/10.1097\/CAD.0000000000000890 (2020).","journal-title":"Anticancer Drugs."},{"issue":"3","key":"8752_CR2","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.3892\/mmr.2014.1888","volume":"9","author":"J Liu","year":"2014","unstructured":"Liu, J., Liu, Y., Ren, Y., Kang, L. & Zhang, L. Transmembrane protein with unknown function 16A overexpression promotes glioma formation through the nuclear factor-\u03baB signaling pathway. Mol. Med. Rep. 9(3), 1068\u20131074. https:\/\/doi.org\/10.3892\/mmr.2014.1888 (2014).","journal-title":"Mol. Med. Rep."},{"issue":"8\u20139","key":"8752_CR3","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1038\/s41417-021-00414-5","volume":"29","author":"J Li","year":"2022","unstructured":"Li, J. et al. TMEM158 promotes the proliferation and migration of glioma cells via STAT3 signaling in glioblastomas. Cancer Gene Ther. 29(8\u20139), 1117\u20131129. https:\/\/doi.org\/10.1038\/s41417-021-00414-5 (2022).","journal-title":"Cancer Gene Ther."},{"issue":"13","key":"8752_CR4","doi-asserted-by":"publisher","first-page":"1029270","DOI":"10.3389\/fgene.2022.1029270","volume":"20","author":"F Yang","year":"2023","unstructured":"Yang, F., Zhang, X., Wang, X., Xue, Y. & Liu, X. The new oncogene transmembrane protein 60 is a potential therapeutic target in glioma. Front. Genet. 20(13), 1029270. https:\/\/doi.org\/10.3389\/fgene.2022.1029270 (2023).","journal-title":"Front. Genet."},{"issue":"1","key":"8752_CR5","doi-asserted-by":"publisher","first-page":"11782","DOI":"10.1038\/s41598-024-60414-x","volume":"14","author":"JL Chen","year":"2024","unstructured":"Chen, J. L. et al. Down-regulation of KLRB1 is associated with increased cell growth, metastasis, poor prognosis, as well as a dysfunctional immune microenvironment in LUAD. Sci. Rep. 14(1), 11782. https:\/\/doi.org\/10.1038\/s41598-024-60414-x (2024).","journal-title":"Sci. Rep."},{"issue":"4","key":"8752_CR6","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1002\/ijc.34329","volume":"152","author":"AB Khan","year":"2023","unstructured":"Khan, A. B. et al. CXCR4 expression is associated with proneural-to-mesenchymal transition in glioblastoma. Int. J. Cancer 152(4), 713\u2013724. https:\/\/doi.org\/10.1002\/ijc.34329 (2023).","journal-title":"Int. J. Cancer"},{"issue":"11","key":"8752_CR7","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3389\/fgene.2020.00242","volume":"20","author":"Q Guo","year":"2020","unstructured":"Guo, Q. et al. Evaluation of the prognostic value of STEAP1 in lung adenocarcinoma and insights into its potential molecular pathways via bioinformatic analysis. Front. Genet. 20(11), 242. https:\/\/doi.org\/10.3389\/fgene.2020.00242 (2020).","journal-title":"Front. Genet."},{"issue":"12","key":"8752_CR8","doi-asserted-by":"publisher","first-page":"10909","DOI":"10.2147\/CMAR.S246030","volume":"30","author":"S Shao","year":"2020","unstructured":"Shao, S., Fan, Y., Zhong, C., Zhu, X. & Zhu, J. Coactosin-Like protein (COTL1) promotes glioblastoma (GBM) growth in vitro and in vivo. Cancer Manag. Res. 30(12), 10909\u201310917. https:\/\/doi.org\/10.2147\/CMAR.S246030 (2020).","journal-title":"Cancer Manag. Res."},{"issue":"7","key":"8752_CR9","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1089\/jir.2022.0063","volume":"42","author":"JL Romanet","year":"2022","unstructured":"Romanet, J. L., Cupo, K. L. & Yoder, J. A. Knockdown of transmembrane protein 150A (TMEM150A) results in increased production of multiple cytokines. J. Interferon. Cytokine Res. 42(7), 336\u2013342. https:\/\/doi.org\/10.1089\/jir.2022.0063 (2022).","journal-title":"J. Interferon. Cytokine Res."},{"issue":"12","key":"8752_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0294144","volume":"18","author":"ST Fan","year":"2023","unstructured":"Fan, S. T. et al. Overexpression of TMEM150A in glioblastoma multiforme patients correlated with dismal prognoses and compromised immune statuses. PLoS ONE 18(12), e0294144. https:\/\/doi.org\/10.1371\/journal.pone.0294144 (2023).","journal-title":"PLoS ONE"},{"key":"8752_CR11","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-024-04726-y","author":"L Cai","year":"2024","unstructured":"Cai, L. et al. TRIM37 interacts with EZH2 to epigenetically suppress PTCH1 and regulate stemness in glioma stem cells through sonic hedgehog pathway. J. Neurooncol. https:\/\/doi.org\/10.1007\/s11060-024-04726-y (2024).","journal-title":"J. Neurooncol."},{"issue":"1","key":"8752_CR12","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s10020-024-00857-0","volume":"30","author":"H Zhang","year":"2024","unstructured":"Zhang, H. et al. Unveiling the therapeutic potential of IHMT-337 in glioma treatment: Targeting the EZH2-SLC12A5 axis. Mol. Med. 30(1), 91. https:\/\/doi.org\/10.1186\/s10020-024-00857-0 (2024).","journal-title":"Mol. Med."},{"key":"8752_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-024-04681-5","author":"T Yan","year":"2024","unstructured":"Yan, T. et al. ZNF384 transcriptionally activated MGST1 to confer TMZ resistance of glioma cells by negatively regulating ferroptosis. Cancer Chemother. Pharmacol. https:\/\/doi.org\/10.1007\/s00280-024-04681-5 (2024).","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"2","key":"8752_CR14","doi-asserted-by":"publisher","first-page":"378","DOI":"10.3390\/biomedicines12020378","volume":"12","author":"M Shi","year":"2024","unstructured":"Shi, M., Sun, D., Deng, L., Liu, J. & Zhang, M. J. SRPK1 promotes glioma proliferation, migration, and invasion through activation of wnt\/\u03b2-catenin and JAK-2\/STAT-3 signaling pathways. Biomedicines 12(2), 378. https:\/\/doi.org\/10.3390\/biomedicines12020378 (2024).","journal-title":"Biomedicines"},{"issue":"4","key":"8752_CR15","doi-asserted-by":"publisher","first-page":"992","DOI":"10.21037\/tcr-23-449","volume":"12","author":"X Zheng","year":"2023","unstructured":"Zheng, X. et al. N6-methyladenosine reader IGF2BP3 as a prognostic Biomarker contribute to malignant progression of glioma. Transl. Cancer Res. 12(4), 992\u20131005. https:\/\/doi.org\/10.21037\/tcr-23-449 (2023).","journal-title":"Transl. Cancer Res."},{"issue":"1","key":"8752_CR16","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s13046-018-0864-6","volume":"37","author":"J Zhang","year":"2018","unstructured":"Zhang, J. et al. LGR5, a novel functional glioma stem cell marker, promotes EMT by activating the Wnt\/\u03b2-catenin pathway and predicts poor survival of glioma patients. J. Exp. Clin. Cancer Res. 37(1), 225. https:\/\/doi.org\/10.1186\/s13046-018-0864-6 (2018).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"8752_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2024.155278","volume":"256","author":"Y Zhang","year":"2024","unstructured":"Zhang, Y. et al. PSMA2 promotes glioma proliferation and migration via EMT. Pathol. Res. Pract. 256, 155278. https:\/\/doi.org\/10.1016\/j.prp.2024.155278 (2024).","journal-title":"Pathol. Res. Pract."},{"issue":"4","key":"8752_CR18","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/carcin\/bgad096","volume":"45","author":"J Zhang","year":"2024","unstructured":"Zhang, J., Li, R., Zhang, H., Wang, S. & Zhao, Y. ITGA2 as a prognostic factor of glioma promotes GSCs invasion and EMT by activating STAT3 phosphorylation. Carcinogenesis 45(4), 235\u2013246. https:\/\/doi.org\/10.1093\/carcin\/bgad096 (2024).","journal-title":"Carcinogenesis"},{"issue":"6","key":"8752_CR19","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1200\/JCO.21.01497","volume":"40","author":"M Reck","year":"2022","unstructured":"Reck, M., Remon, J. & Hellmann, M. D. First-line immunotherapy for non-small-cell lung cancer. J. Clin. Oncol. 40(6), 586\u2013597. https:\/\/doi.org\/10.1200\/JCO.21.01497 (2022).","journal-title":"J. Clin. Oncol."},{"issue":"8","key":"8752_CR20","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1038\/s41591-023-02453-x","volume":"29","author":"B Routy","year":"2023","unstructured":"Routy, B. et al. Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: A phase I trial. Nat. Med. 29(8), 2121\u20132132. https:\/\/doi.org\/10.1038\/s41591-023-02453-x (2023).","journal-title":"Nat. Med."},{"issue":"9","key":"8752_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2023.103669","volume":"28","author":"M Al Zein","year":"2023","unstructured":"Al Zein, M. et al. Immunotherapy and immunoevasion of colorectal cancer. Drug Discov Today. 28(9), 103669. https:\/\/doi.org\/10.1016\/j.drudis.2023.103669 (2023).","journal-title":"Drug Discov Today."},{"issue":"9","key":"8752_CR22","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s00262-024-03754-x","volume":"73","author":"H Eric","year":"2024","unstructured":"Eric, H. et al. High expression of PD-L1 on conventional dendritic cells in tumour-draining lymph nodes is associated with poor prognosis in oral cancer. Cancer Immunol. Immunother. 73(9), 165. https:\/\/doi.org\/10.1007\/s00262-024-03754-x (2024).","journal-title":"Cancer Immunol. Immunother."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08752-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08752-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08752-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T06:10:27Z","timestamp":1752214227000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08752-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,11]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8752"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-08752-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,11]]},"assertion":[{"value":"28 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"25017"}}